Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
Perspective Therapeutics
Ocellaris Pharma, Inc.
Eli Lilly and Company
Hoffmann-La Roche
Tanabe Pharma America, Inc.
Turning Point Therapeutics, Inc.
Cancer Research UK
Hutchmed
Intensity Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
TransThera Sciences (Nanjing), Inc.
Kineta Inc.
Nektar Therapeutics
Institut Bergonié
Ludwig Institute for Cancer Research
ImmVira Pharma Co. Ltd
NKGen Biotech, Inc.
Duke University